20 June 2013
Keywords: nice, rules, out, dementia, drugs, mild, ad
Article | 16 October 2006
The UK's National Institute for Health and Clinical Excellence (NICE) has stood by its earlier decision to deny access to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 October 2006
19 June 2013
© 2013 thepharmaletter.com